Quotient
The firm said it is also eyeing other testing markets for a platform that does immunohematology, serology, and molecular testing.
360Dx Index Up 7 Percent in June, Rebounding From May Downturn
Of the 30 companies in the index, 24 firms saw their stock prices increase, while six firms' share prices decreased.Â
Quotient Limited Fiscal Q4 Revenues Rise 10 Percent on Reagent Sales
The firm said it expects European field trials for its expanded MosaiQ immunohematology microarray to commence in June and US field trials to start soon after.
May Lag for Many Dx Firms' Stock Prices as 360Dx Index Drops 4 Percent
Of the 30 companies in the index, 18 firms saw their stock prices decrease, while 12 firms' share prices increased.Â
Quotient Limited to Sell $95M of Senior Notes in Private Offering
The company said it plans to use the proceeds to continue developing its multiplexing MosaiQ platform and to prepare for its commercial launch.